For this purpose, we designed and synthesized ASOs targeting the mRNA encoding the transmembrane vesicular trafficking protein SYT13 that mediates synapsis and vesicle metabolism, which we previously identified as a driver of peritoneal metastasis of gastric cancer. Here, SYT13 is linked to gastric cancer.